Rifampicin tolerance and growth fitness among isoniazid-resistant clinical Mycobacterium tuberculosis isolates from a longitudinal study (eLife, 2024)

(untitled) - Vijay, S; Bao, NLH; Vinh, DN; Nhat, LTH; Thu, DDA; Quang, NL; Trieu, LPT; Nhung, HN; Ha, VTN; Thai, PVK; Ha, DTM; Lan, NH; et al.